Zoe Boyer‐Díaz
18 works · 615 citations · h-index 9
Top works
- Animal models for liver disease – A practical approach for translational research
- Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease
- Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte‐Mediated Paracrine Mechanism
- Targeting 5-Hydroxytryptamine Receptor 1A in the Portal Vein to Decrease Portal Hypertension
- GNIP1 E3 ubiquitin ligase is a novel player in regulating glycogen metabolism in skeletal muscle
- Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical
- A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease
- New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of The Human Disease
- Sex-specific differences in preclinical models of advanced chronic liver disease and portal hypertension
- GTX-11 improves portal hypertension, liver fibrosis, and sinusoidal cells phenotype in experimental MASH
- GTX-011 improves fibrosis and hepatic stellate cells phenotype in human precision cut liver slices
- FRI-110-A nutraceutical supplement rich in docosahexaenoic acid improves portal hypertension in a pre-clinical model of chronic liver disease
- FRI-324-Introducing a new pre-clinical model of advanced NASH that mimics the main pathophysiologic characteristics and transcriptomic signature of the human disease
- THU-176 Sex-specific differences in preclinical models of advanced chronic liver disease and portal hypertension